1 / 6

North America Cell Line Development Market to reach USD 2.7 bn by 2024

North America cell line development market was valued at USD 1.1 billion in 2017 and is expected to grow 12.5% CAGR from 2018 to 2024.

madhurip3918
Download Presentation

North America Cell Line Development Market to reach USD 2.7 bn by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. North America Cell Line Development Market share to Surpass $2.7 Bn by 2024: Graphical Research ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  2. Key Insights from North America Cell Line Development Market: • Graphical Research, Inc. says, North America Cell Line Development Market size is set to exceed USD 2.7 billion by 2024. • Growing demand for monoclonal antibodies, technological advancements in cell line development equipment and growing number of cancer incidences will drive North America cell line development market. • Rising vaccine production, growth of biotechnology industry and high healthcare expenditure will drive business growth. • Hybridomas cell line type segment is forecasted to witness robust growth during the forecast timeframe. • Growing awareness about cell-based therapy, innovation in development of biologics and rising prevalence of cancer will stimulate growth of Canada cell line development market. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  3. Continued... • Key industry players operating in North America cell line development market are Selexis, Sartorius, Lonza Group, Samsung Biologics, WuXiAppTec, GE Healthcare, Thermo Fisher Scientific, The European Collection of Cell Cultures, Sigma-Aldrich (Merck), GVK BIO, and Progenitor Cell Therapy. • Industry players are adopting strategies including merger, acquisition and strategic collaboration and partnership to expand their product portfolio as well as augment consumer base in the industry. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  4. U.S. Cell Line Development Market, By Product, 2013 – 2024 (USD Bn) ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  5. Browse Full Market Research Report On North America Cell Line Development Market @ https://bit.ly/2QnZGuz Request for a Sample of this Research Report @ https://bit.ly/2x24GMp ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  6. Stay In Touch With Us For: Website: www.graphicalresearch.com Social Media: Assured Quality On-Time Delivery Payment Security Industry Experts ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

More Related